Andrew Smith, MD, PhD

Andrew Smith, MD, PhD 


August 26, 2022 — AI Metrics, an early stage radiology software company, announces changes to its executive leadership team, naming Dr. Andrew Smith as Chief Medical Officer and appointing Bob Jacobus as CEO. 

AI Metrics, launched in 2019 by Jacobus, Paige Severino, and radiologist and researcher Dr. Smith is developing software to more accurately assess cancer treatment effectiveness. The founders set out to leverage augmented intelligence in innovative imaging software solutions, improve radiology workflows, quantitative metrics, and reporting in clinical practice and clinical trials. 

Dr. Smith, the Company’s initial CEO, will take on the newly created role of Chief Medical Officer while continuing his role as Chairman of the Board. Dr. Smith is currently a Radiologist and Oncologic Imager at the University of Alabama at Birmingham. He is Vice Chair of Clinical Research, Chief of Body CT, and is also the Clinical Director of AI at the University’s Heersink Institute of Biomedical Innovation

“I am excited to take on the role of Chief Medical Officer at AI Metrics, where I will be able to focus on the clinical aspects, the necessary research and new and innovative advancements needed in radiology and cancer treatment evaluation,” said Dr. Smith. “AI Metrics was created to utilize advanced technologies to help standardize reporting with greater inter-observer agreement, while decreasing variations in impressions – making it more useful and easier for oncologists to interpret data and information for their patients.” 

Jacobus was the company’s initial COO and has more than 20 years of experience in founding, investing in and raising capital for startups. He is an experienced financial professional, with significant industry experience in investment banking, early-stage ventures, financial management, new business development, engineering, operations, and manufacturing. Jacobus also has deep experience in the biotech, medical products manufacturing, software, transportation and insurance sectors. 

​​"I am honored to lead this innovative company that is delivering solutions to radiologists who work on important issues such as saving lives and working with advanced cancers,” said Jacobus. “My role as CEO is to lead AI Metrics as it helps solve real radiology pain points using AI technologies to improve accuracy, consistency, and efficiency in radiology.” 

For more information: https://www.aimetrics.com/ 

 


Related Content

News | Radiopharmaceuticals and Tracers

May 27, 2026 — Subtle Medical has received FDA clearance for its SubtleHD (PET), the company's next-generation AI ...

Time May 27, 2026
arrow
News | FDA

May 19, 2026 — DeepHealth has received the CE Mark for the Brain Health and Brain Age solutions within its Neuro Suite ...

Time May 26, 2026
arrow
News | Cardiac Imaging

May 21, 2026 — A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s ...

Time May 22, 2026
arrow
News | X-Ray

May 21, 2026 — RADIN Health and AZmed have announced the expansion of their strategic partnership and enhance radiology ...

Time May 22, 2026
arrow
News | Digital Pathology

May 7, 2026 — Roche has entered into a definitive merger agreement to acquire PathAI, a U.S.-based company in digital ...

Time May 21, 2026
arrow
News | Computed Tomography (CT)

May 12, 2026 – Bracco Imaging S.p.A. has purchased a mobile photon-counting CT scanner from MARS Bioimaging to support ...

Time May 20, 2026
arrow
Feature | Enterprise Imaging | Kyle Hardner

For radiology departments, the imbalance between surging imaging volume and a shortage of trained radiologists is taking ...

Time May 20, 2026
arrow
News | Interventional Radiology

May 12, 2026 — Siemens Healthineers has received clearance from the Food and Drug Administration for six new systems in ...

Time May 12, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

May 11, 2026 – At the International Society for Magnetic Resonance in Medicine (ISMRM) 2026 Annual Meeting, GE ...

Time May 11, 2026
arrow
News | FDA

May 6, 2026 — Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer ...

Time May 07, 2026
arrow
Subscribe Now